Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
551 | 3 | CIRCULATING TUMOR CELLS//MASPIN//CANCER ASSOCIATED FIBROBLASTS | 18487 |
2466 | 2 | CHEMOSENSITIVITY TEST//HUMANIZED MICE//SCID MICE | 4221 |
6032 | 1 | CHEMOSENSITIVITY TEST//HISTOCULTURE DRUG RESPONSE ASSAY//CHEMOSENSITIVITY | 1569 |
8294 | 1 | HUMANIZED MICE//SCID MICE//SCID MOUSE | 1297 |
17449 | 1 | PATIENT DERIVED XENOGRAFT//FP3//TUMORGRAFTS | 627 |
23962 | 1 | DRUG EFFECT ON BRAIN//OXOPLATINUM//BLOCKADE OF RAS ONCOGENES | 351 |
27782 | 1 | DECLOPRAMIDE 3 CHLOROPROCAINAMIDE//SECT MOL ECOGENET//TUMOR XENOGRAFT MODELS | 241 |
33641 | 1 | METHYL 3 5 DIIODO 44 METHOXYPHENOXY BENZOATE//CLASTO BETA LACTONE//CURSO POS PATOL CIENCIAS CLIN | 136 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CHEMOSENSITIVITY TEST | authKW | 215468 | 1% | 53% | 54 |
2 | HUMANIZED MICE | authKW | 202268 | 2% | 37% | 74 |
3 | SCID MICE | authKW | 108721 | 2% | 18% | 79 |
4 | PATIENT DERIVED XENOGRAFT | authKW | 107774 | 1% | 34% | 43 |
5 | SCID MOUSE | authKW | 106406 | 1% | 24% | 59 |
6 | HISTOCULTURE DRUG RESPONSE ASSAY | authKW | 93295 | 0% | 63% | 20 |
7 | HU PBL SCID | authKW | 81277 | 0% | 78% | 14 |
8 | CHEMOSENSITIVITY | authKW | 69143 | 3% | 9% | 109 |
9 | CHEMOSENSITIVITY ASSAY | authKW | 61620 | 0% | 49% | 17 |
10 | COLLAGEN GEL DROPLET EMBEDDED CULTURE DRUG SENSITIVITY TEST | authKW | 56446 | 0% | 69% | 11 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 33793 | 47% | 0% | 1967 |
2 | Immunology | 3141 | 14% | 0% | 611 |
3 | Hematology | 1884 | 7% | 0% | 302 |
4 | CYTOLOGY & HISTOLOGY | 1361 | 1% | 1% | 38 |
5 | Medicine, Research & Experimental | 1077 | 7% | 0% | 301 |
6 | Pathology | 514 | 4% | 0% | 158 |
7 | Transplantation | 250 | 2% | 0% | 84 |
8 | Radiology, Nuclear Medicine & Medical Imaging | 208 | 4% | 0% | 170 |
9 | Surgery | 184 | 6% | 0% | 249 |
10 | Cell Biology | 160 | 5% | 0% | 225 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CLIN GYNECOL OBSTET ST HEDWIG | 23886 | 0% | 80% | 4 |
2 | CHEMOSENSITIVITATESTUNGEN | 22394 | 0% | 100% | 3 |
3 | AFFILIATED ZHUJI HOSP | 19188 | 0% | 43% | 6 |
4 | BILL MELINDA GATES FDN GRAND CHALLENGES GLOBAL | 14930 | 0% | 100% | 2 |
5 | FDN BLOOD TRANSFUS | 14930 | 0% | 100% | 2 |
6 | MAXILLIO IAL SURG | 14930 | 0% | 100% | 2 |
7 | SECT MOL ECOGENET | 14926 | 0% | 50% | 4 |
8 | ZHEJIANG CANC HOSP | 14349 | 0% | 38% | 5 |
9 | MICHAEL DARMADY | 11939 | 0% | 40% | 4 |
10 | ABT MOL TOXIKOL E080 | 9952 | 0% | 67% | 2 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | RECENT RESULTS IN CANCER RESEARCH | 14528 | 1% | 6% | 32 |
2 | INTERNATIONAL JOURNAL OF CELL CLONING | 14478 | 1% | 7% | 29 |
3 | BRITISH JOURNAL OF CANCER | 8667 | 3% | 1% | 147 |
4 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 7953 | 1% | 2% | 45 |
5 | CANCER RESEARCH | 6378 | 4% | 0% | 187 |
6 | ANTICANCER RESEARCH | 5805 | 3% | 1% | 125 |
7 | EXPERIMENTAL CELL BIOLOGY | 5321 | 0% | 4% | 17 |
8 | CANCER TREATMENT REPORTS | 4573 | 1% | 2% | 37 |
9 | CELL AND TISSUE KINETICS | 4092 | 0% | 3% | 18 |
10 | ANTI-CANCER DRUGS | 3328 | 1% | 1% | 39 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |